Clinical Trial: A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Phase II Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma
Brief Summary:
To learn if response-adapted, ultra-low dose radiation therapy can help to control MZL.This means participates first receive lower does of radiation therapy and then, based on how the disease responds, may receive higher doses after that.
Read more